Pure Global AI
NCT05774431Recruiting

Disparities in the Proportion of Ticagrelor and Prasugrel-eligible Patients With Acute Coronary Syndrome in a Real-world Registry

University Hospital HeidelbergClinicalTrials.govother
Verified
Study focus
Disease/Condition
Acute Myocardial Infarction
Drug/Device/Intervention
There was no intervention necessary.
Study type
Observational
Intervention type
other
Sponsor & location
Primary sponsor
University Hospital Heidelberg
Location
Heidelberg, Germany
Timeline & enrollment
Phase
N/A
Start date
Mar 13, 2023
End date
Dec 30, 2023
Enrollment
6789 participants
Primary outcome

Comparison of Eligible Patients for Dual Antiplatelet Therapy: ASS and Ticagrelor vs ASS and Prasugrel

Summary

The primary objective of this study is to compare patients eligible for ASS and Ticagrelor
 against those eligible for ASS and Prasugrel. The available information regarding relative
 and absolute exclusion criteria outlines reasons for disqualification from either drug.
 
 The secondary objectives of the study are to:
 
 - Assess the proportion of patients who received ASS and Ticagrelor in the study cohort.
 
 - Compare the proportion of patients who received ASS and Ticagrelor against the
 proportion of patients who qualify for DAPT with ASS and Ticagrelor (eligible group).
 
 - Describe the antithrombotic treatment, including antiplatelet monotherapies, and
 antiplatelet therapies with or without anticoagulation.
 
 The investigators will use these objectives to evaluate the effectiveness and appropriateness
 of the different antiplatelet therapies in the study population. Participants will not be
 personally identified in any reports or publications resulting from this study.

ICD-10 classifications
Acute myocardial infarctionAcute myocardial infarction, unspecifiedAcute subendocardial myocardial infarctionCertain current complications following acute myocardial infarctionOther current complications following acute myocardial infarction
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05774431
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT05774431 through Pure Global AI's free database. This phase not specified trial is sponsored by University Hospital Heidelberg and is currently Recruiting. The study focuses on Acute Myocardial Infarction. Target enrollment is 6789 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.